Evidence of Redox Imbalance in a Patient with Succinic Semialdehyde Dehydrogenase Deficiency
Overview
Affiliations
The pathophysiology of succinic semialdehyde dehydrogenase (SSADH) deficiency is not completely understood. Oxidative stress, mitochondrial pathology, and low reduced glutathione levels have been demonstrated in mice, but no studies have been reported in humans. We report on a patient with SSADH deficiency in whom we found low levels of blood reduced glutathione (GSH), and elevations of dicarboxylic acids in urine, suggestive of possible redox imbalance and/or mitochondrial dysfunction. Thus, targeting the oxidative stress axis may be a potential therapeutic approach if our findings are confirmed in other patients.
Chiba N, Suzuki S, Enriquez-Vera D, Utsunomiya A, Kubuki Y, Hidaka T Heliyon. 2024; 10(20):e38507.
PMID: 39640675 PMC: 11619966. DOI: 10.1016/j.heliyon.2024.e38507.
Schreiber J, Wiggs E, Cuento R, Norato G, Dustin I, Rolinski R J Child Neurol. 2021; 36(13-14):1189-1199.
PMID: 34015244 PMC: 8605041. DOI: 10.1177/08830738211012804.
Xie C, Li Z, Bai F, Hu Z, Zhang W, Li Z PLoS One. 2020; 15(9):e0239372.
PMID: 32966327 PMC: 7510979. DOI: 10.1371/journal.pone.0239372.
Succinic Semialdehyde Dehydrogenase Deficiency: An Update.
Didiasova M, Banning A, Brennenstuhl H, Jung-Klawitter S, Cinquemani C, Opladen T Cells. 2020; 9(2).
PMID: 32093054 PMC: 7072817. DOI: 10.3390/cells9020477.
Novel mutations in two unrelated Italian patients with SSADH deficiency.
Balzarini M, Rovelli V, Paci S, Rigoldi M, Sanna G, Pillai S Metab Brain Dis. 2019; 34(5):1515-1518.
PMID: 31267348 DOI: 10.1007/s11011-019-00453-w.